首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷分子呈像/呈影劑

市場調查報告書

商品編碼

1447883

全球造影劑市場規模、佔有率、成長分析，依應用（醫院、診所）、依產品（碘造影劑、微泡造影劑）、依模式（超音波、X 光/CT） - 產業預測 2024-2031

Global Contrast Agents Market Size, Share, Growth Analysis, By Application(Hospitals, Clinics), By Product(Iodinated Contrast Media, Microbubble Contrast Media), By Modality(Ultrasound, X-ray/CT) - Industry Forecast 2024-2031

出版日期: 2024年02月29日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球造影劑市場規模為52.2億美元，預計將從2023年的53.6億美元成長到2031年的66.4億美元，預測期內（2024-2031年）複合CAGR為2.71%。

全球造影劑市場是醫學影像領域一個充滿活力的領域，其特點是穩定成長和技術進步。造影劑在診斷影像過程中增強體內結構的可視性方面發揮關鍵作用，從而促進各個醫學專業的準確診斷和治療計劃。根據最近的分析，該市場經歷了顯著擴張，主要是由於慢性病盛行率不斷上升、人口老化以及對先進診斷技術的需求不斷成長。此外，造影劑配方的持續創新，例如開發更安全、更有效且副作用最小的造影劑，進一步推動了市場成長。值得注意的是，市場格局也受到不斷發展的監管框架和醫療保健政策的影響，影響產品核准、市場進入策略和競爭動態。在各個地理區域中，造影劑市場呈現出不均勻的成長模式，北美和歐洲等已開發經濟體由於其強大的醫療基礎設施、高醫療支出和先進成像技術的早期採用而佔據了大量市場佔有率。相反，在改善醫療基礎設施、增加可支配收入和增加醫療投資的推動下，亞太和拉丁美洲的新興經濟體為市場擴張提供了利潤豐厚的機會。然而，定價壓力、嚴格的監管要求以及替代成像方式的出現等課題給市場參與者帶來了重大障礙，需要策略合作、產品差異化和市場滲透策略來保持競爭力和維持成長。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 歐洲其他地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 拉丁美洲其他地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- MEA 的其餘部分

競爭格局

前 5 名企業比較
2021 年關鍵參與者的市場定位
主要市場參與者所採取的策略
最佳制勝策略
近期市集活動
主要公司市佔率（%），2021年

主要公司簡介

Bayer AG
General Electric Company
Guerbet
Bracco Diagnostic, Inc.
Nano Therapeutics Pvt. Ltd.
Lantheus Medical Imaging, Inc.
iMax
Trivitron Healthcare
GE Healthcare
Hengrui Medicine
YRPG
BeiLu Pharma
JB Chemicals and Pharmaceuticals Ltd.
Unijules Life Sciences Ltd.
SANOCHEMIA Pharmazeutika GmbH
Taejoon Pharm

簡介目錄

Product Code: SQMIG15A2297

Global Contrast Agents Market size was valued at USD 5.22 billion in 2022 and is poised to grow from USD 5.36 billion in 2023 to USD 6.64 billion by 2031, growing at a CAGR of 2.71% in the forecast period (2024-2031).

The global contrast agents' market is a dynamic sector within the medical imaging field, characterized by steady growth and technological advancements. Contrast agents play a pivotal role in enhancing the visibility of internal body structures during diagnostic imaging procedures, thereby facilitating accurate diagnoses and treatment planning across various medical specialties. As of recent analysis, the market has experienced notable expansion, driven primarily by the increasing prevalence of chronic diseases, the growing aging population, and the rising demand for advanced diagnostic techniques. Moreover, the continual innovation in contrast agent formulations, such as the development of safer and more effective agents with minimal side effects, has further propelled market growth. Notably, the market landscape is also shaped by evolving regulatory frameworks and healthcare policies, influencing product approvals, market entry strategies, and competitive dynamics. Across geographical regions, the contrast agents market exhibits non-uniform growth patterns, with developed economies like North America and Europe holding substantial market shares attributed to their robust healthcare infrastructure, high healthcare expenditure, and early adoption of advanced imaging technologies. Conversely, emerging economies in Asia-Pacific and Latin America present lucrative opportunities for market expansion, fueled by improving healthcare infrastructures, rising disposable incomes, and increasing investments in healthcare. However, challenges such as pricing pressures, stringent regulatory requirements, and the emergence of alternative imaging modalities pose significant obstacles to market players, necessitating strategic collaborations, product differentiation, and market penetration strategies to maintain competitiveness and sustain growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Contrast Agents Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Contrast Agents Market Segmental Analysis

The global contrast agents' market is segmented on the basis of application, product, modality and region. Based on application the market is segmented as, hospitals, clinics. Based on product the market is segmented as iodinated contrast media, microbubble contrast Media. Based on modality the market is segmented as ultrasound, X-ray/CT. Based on region the market is segmented as, North America, Europe, Asia-Pacific, MEA, and Latin America.

Drivers of the Global Contrast Agents Market

The global contrast agents market has experienced significant growth in recent years, driven by various factors such as technological advancements, increasing prevalence of chronic diseases, and rising demand for diagnostic imaging procedures. One notable driver of this market is the growing adoption of diagnostic imaging techniques across various medical fields, including radiology, cardiology, oncology, and neurology. Contrast agents play a crucial role in enhancing the visibility of internal body structures during imaging procedures such as magnetic resonance imaging (MRI), computed tomography (CT), and ultrasound. With the continuous advancements in imaging technologies, there has been a greater emphasis on achieving higher resolution and improved diagnostic accuracy, thereby driving the demand for contrast agents.

Restraints in the Global Contrast Agents Market

However, despite the growth opportunities, the market also faces certain restraints, with one significant factor being the high cost associated with contrast agents and imaging procedures. The expense involved in acquiring imaging equipment, administering contrast agents, and interpreting imaging results can pose a financial burden on healthcare systems and patients alike. This cost factor may limit the accessibility of advanced imaging techniques, particularly in regions with limited healthcare infrastructure or economic constraints, thereby impeding market growth to some extent.

Market Trends of the Global Contrast Agents Market

On the other hand, a notable trend shaping the contrast agents' market is the increasing focus on the development of novel contrast agents with improved safety profiles and enhanced imaging properties. There is a growing demand for contrast agents that offer better tissue-specific targeting, reduced toxicity, and prolonged imaging enhancement, while also complying with stringent regulatory requirements. Manufacturers are investing in research and development activities to innovate new formulations, including nanoparticle-based agents, targeted contrast agents, and theranostic agents capable of both imaging and therapeutic functions. This trend underscores the ongoing efforts to address the evolving needs of healthcare professionals and patients, driving advancements in contrast agent technology and expanding the market's potential.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Contrast Agents Market by Application

Market Overview
Hospitals
Clinics

Global Contrast Agents Market by Product

Market Overview
Iodinated Contrast Media
Microbubble Contrast Media

Global Contrast Agents Market by Modality

Market Overview
Ultrasound
X-ray/CT

Global Contrast Agents Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Bayer AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
General Electric Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Guerbet
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bracco Diagnostic, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nano Therapeutics Pvt. Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lantheus Medical Imaging, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
iMax
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Trivitron Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hengrui Medicine
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
YRPG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BeiLu Pharma
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
J.B. Chemicals and Pharmaceuticals Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Unijules Life Sciences Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SANOCHEMIA Pharmazeutika GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Taejoon Pharm
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments